ID24430A - Turunan-turunan benzamidina - Google Patents

Turunan-turunan benzamidina

Info

Publication number
ID24430A
ID24430A IDW20000609A ID20000609A ID24430A ID 24430 A ID24430 A ID 24430A ID W20000609 A IDW20000609 A ID W20000609A ID 20000609 A ID20000609 A ID 20000609A ID 24430 A ID24430 A ID 24430A
Authority
ID
Indonesia
Prior art keywords
benzamidina
benzamidina down
Prior art date
Application number
IDW20000609A
Other languages
English (en)
Indonesian (id)
Inventor
Dieter Dorsch
Horst Juraszyk
Hanns Wurziger
Sabine Bernotat-Danielowski
Guido Melzer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID24430A publication Critical patent/ID24430A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IDW20000609A 1997-10-01 1998-09-16 Turunan-turunan benzamidina ID24430A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743435A DE19743435A1 (de) 1997-10-01 1997-10-01 Benzamidinderivate

Publications (1)

Publication Number Publication Date
ID24430A true ID24430A (id) 2000-07-20

Family

ID=7844313

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000609A ID24430A (id) 1997-10-01 1998-09-16 Turunan-turunan benzamidina

Country Status (19)

Country Link
US (1) US6492368B1 (fr)
EP (1) EP1025086B1 (fr)
JP (1) JP2001518467A (fr)
KR (1) KR20010024386A (fr)
CN (1) CN1272107A (fr)
AR (1) AR017164A1 (fr)
AT (1) ATE243681T1 (fr)
AU (1) AU736080B2 (fr)
BR (1) BR9812699A (fr)
CA (1) CA2305568A1 (fr)
DE (2) DE19743435A1 (fr)
HU (1) HUP0004306A3 (fr)
ID (1) ID24430A (fr)
NO (1) NO20001687D0 (fr)
PL (1) PL339173A1 (fr)
RU (1) RU2194044C2 (fr)
SK (1) SK282799B6 (fr)
WO (1) WO1999016751A1 (fr)
ZA (1) ZA988937B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010015639A (ko) 1997-09-30 2001-02-26 스즈키 다다시 술포닐 유도체
DE69921994T2 (de) 1998-05-02 2005-12-01 Astrazeneca Ab Heterozyklische verbindungen mit faktor xa hemmender wirkung
GB9809349D0 (en) * 1998-05-02 1998-07-01 Zeneca Ltd Heterocyclic derivatives
US6747023B1 (en) * 1998-08-11 2004-06-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
EP1088821A1 (fr) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Derives des sulfamides pharmaceutiquement actifs
EP1829535A3 (fr) * 1999-10-27 2007-10-24 Tanox, Inc. Antagonistes de facteur de tissus et leurs procédés d'utilisation
US6608066B1 (en) * 1999-10-27 2003-08-19 Sunol Molecular Corporation Tissue factor antagonists and methods of use thereof
DE10035928A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035927A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
EP1193268A1 (fr) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Dérivés de sulfonamide pharmaceutiquement actifs comportant des groupes lipophiles ainsi que ionisables comme inhibiteurs de protéine junkinases
EP1193267A1 (fr) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Composés de sulfonamides hydrophiles pharmaceutiquement actifs
EP1193256A1 (fr) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Derivés de benzénesulphonamide pharmaceutiquemant actifs comme inhibiteurs de protéines JNK
JP4564713B2 (ja) 2000-11-01 2010-10-20 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
DE10102322A1 (de) 2001-01-19 2002-07-25 Merck Patent Gmbh Phenylderivate
DE10130718A1 (de) * 2001-06-26 2003-01-02 Merck Patent Gmbh Kohlenhydratderivate
CN100445276C (zh) 2002-03-13 2008-12-24 詹森药业有限公司 用作组蛋白去乙酰酶抑制剂的磺酰基衍生物
MXPA04008797A (es) 2002-03-13 2004-11-26 Janssen Pharmaceutica Nv Inhibidores de histona desacetilasa.
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
RU2337099C2 (ru) * 2003-04-03 2008-10-27 Мерк Патент Гмбх Карбонильные соединения
DE10336716A1 (de) * 2003-08-11 2005-03-10 Merck Patent Gmbh Verfahren zur Herstellung von N-Aryl-morpholinonen
BRPI0516106B1 (pt) * 2004-10-14 2021-08-24 Wilex Ag Métodos para purificação e preparação de derivados de 3-hidroxiamidinofenilalanina, e para produção de derivados de 3-amidinofenilalanina
TW200633990A (en) 2004-11-18 2006-10-01 Takeda Pharmaceuticals Co Amide compound
US7906645B2 (en) * 2004-12-24 2011-03-15 Astrazeneca Ab Heterocyclic compounds as ccr2b antagonists
WO2007007588A1 (fr) * 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. Compose comportant un groupe cyclique ayant un noyau plan
US7825122B2 (en) * 2005-12-14 2010-11-02 Amgen Inc. Diaza heterocyclic sulfonamide derivatives and their uses
CA2636929A1 (fr) * 2005-12-21 2007-07-12 Decode Genetics, Ehf Inhibiteurs de biaryl-azote-heterocycle de lta4h pour traiter l'inflammation
GB0525957D0 (en) * 2005-12-21 2006-02-01 Astrazeneca Ab Methods
DE102005061624A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
LT1976828T (lt) 2005-12-29 2017-04-25 Celtaxsys, Inc. Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
CA2659956C (fr) 2006-08-04 2016-01-05 Lewis C. Cantley Inhibiteurs de la pyruvate kinase et procedes de traitement de maladie
JP5464709B2 (ja) 2007-06-08 2014-04-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン/ピペラジン誘導体
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
EP2152271B1 (fr) * 2007-06-08 2015-10-21 Janssen Pharmaceutica, N.V. Dérivés de piperidine/piperazine
ES2536406T3 (es) 2007-06-08 2015-05-25 Janssen Pharmaceutica, N.V. Derivados de piperidina/piperazina
KR101669432B1 (ko) 2007-08-27 2016-10-26 다트 뉴로사이언스 (케이만) 엘티디. 치료적 이속사졸 화합물
JP5656288B2 (ja) * 2007-09-07 2015-01-21 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー ムスカリン受容体アンタゴニストとして有用なグアジニン含有化合物
EP2204368B1 (fr) * 2007-09-21 2014-05-21 Msd K.K. Dérivés de 4-sulfonylpipéridine
PE20100083A1 (es) 2008-06-05 2010-02-17 Janssen Pharmaceutica Nv Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
US20100152197A1 (en) * 2008-12-15 2010-06-17 Astrazeneca Ab (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
NZ595263A (en) 2009-02-26 2013-06-28 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
CA2758071C (fr) 2009-04-06 2018-01-09 Agios Pharmaceuticals, Inc. Modulateurs de pyruvate kinase m2, compositions therapeutiques et methodes d'utilisation associees
TWI598337B (zh) 2009-06-29 2017-09-11 阿吉歐斯製藥公司 治療化合物及組成物
ES2618630T3 (es) * 2009-06-29 2017-06-21 Agios Pharmaceuticals, Inc. Composiciones terapéuticas y métodos de uso relacionados
WO2012083246A1 (fr) 2010-12-17 2012-06-21 Agios Pharmaceuticals, Inc. Nouveaux dérivés de n-(4-(azétidine- 1 - carbonyl) phényl)-(hétéro-) arylsulfonamide en tant que modulateurs de la pyruvate kinase m2 (pmk2)
ES2569712T3 (es) 2010-12-21 2016-05-12 Agios Pharmaceuticals, Inc. Activadores de PKM2 bicíclicos
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
SMT202400081T1 (it) 2011-05-03 2024-03-13 Agios Pharmaceuticals Inc Attivatori della piruvato chinasi per uso in terapia
US9181231B2 (en) 2011-05-03 2015-11-10 Agios Pharmaceuticals, Inc Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
FR2976943B1 (fr) * 2011-06-23 2013-07-12 Metabolys Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
ES2753386T3 (es) 2013-03-13 2020-04-08 Forma Therapeutics Inc Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer
CA2906035A1 (fr) * 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibiteurs de la leucotriene a4 hydrolase
WO2014139144A1 (fr) 2013-03-15 2014-09-18 Agios Pharmaceuticals, Inc. Composés et compositions thérapeutiques
JP6412553B2 (ja) 2013-03-21 2018-10-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Fasn阻害剤としてのピペラジン誘導体
CA2989111C (fr) 2015-06-11 2023-10-03 Agios Pharmaceuticals, Inc. Procedes d'utilisation d'activateurs de la pyruvate kinase
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233503A (en) * 1989-05-15 1991-06-25 Janssen Pharmaceutica Nv Substituted (thio)morpholinyl and piperazinyl alkylphenol ethers
AU8868991A (en) 1990-11-15 1992-06-11 Pentapharm Ag Meta-substituted phenyl alanine derivatives
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
GB9208740D0 (en) 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds
DE4234295A1 (de) * 1992-10-12 1994-04-14 Thomae Gmbh Dr K Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4302485A1 (de) 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
DE69536015D1 (de) 1995-03-30 2009-12-10 Pfizer Prod Inc Chinazolinone Derivate
WO1997002245A1 (fr) * 1995-07-06 1997-01-23 Japan Tobacco Inc. Derives de benzamidoxime et leur utilisation a des fins medicinales
CA2197364A1 (fr) * 1996-02-15 1997-08-16 Toshikazu Suzuki Compose phenolique et methode de preparation
WO1998054164A1 (fr) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Derives de la sulfonamide, leur production et leurs utilisations

Also Published As

Publication number Publication date
BR9812699A (pt) 2000-08-22
HUP0004306A2 (hu) 2001-11-28
ZA988937B (en) 1999-03-31
SK282799B6 (sk) 2002-12-03
RU2194044C2 (ru) 2002-12-10
DE19743435A1 (de) 1999-04-08
EP1025086B1 (fr) 2003-06-25
EP1025086A1 (fr) 2000-08-09
SK4472000A3 (en) 2000-11-07
AU9540798A (en) 1999-04-23
AU736080B2 (en) 2001-07-26
NO20001687L (no) 2000-03-31
NO20001687D0 (no) 2000-03-31
CA2305568A1 (fr) 1999-04-08
CN1272107A (zh) 2000-11-01
WO1999016751A1 (fr) 1999-04-08
DE59808842D1 (de) 2003-07-31
JP2001518467A (ja) 2001-10-16
ATE243681T1 (de) 2003-07-15
PL339173A1 (en) 2000-12-04
KR20010024386A (ko) 2001-03-26
AR017164A1 (es) 2001-08-22
US6492368B1 (en) 2002-12-10
HUP0004306A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
ID22500A (id) Turunan sulfonamida
ID24430A (id) Turunan-turunan benzamidina
DE19810476B4 (de) Laryngomaske
DE59806832D1 (de) Zementationshilfsmittel
ATA93198A (de) Fluoxetinpellets
DE59808121D1 (de) Sulfonylaminocarbonsäuren
DE59808569D1 (de) Fräsbrecherfahrzeug
DE59803185D1 (de) Baulaser
DE59806720D1 (de) Einspritzventil
ATA111897A (de) Kimme
DE59804631D1 (de) Diketopyrrolopyrrolzusammensetzungen
DE59804377D1 (de) Kryoventil
DE59710388D1 (de) Mikropolarimeter
DE59801498D1 (de) Dioxacycloalkan-8-one
DE59808447D1 (de) Kabelhalter
DE59805979D1 (de) Organosilan-oligomere
DE59807879D1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE59806501D1 (de) Spitzenschneider
DE59805053D1 (de) Bogenflexodruckmaschine
ATA86797A (de) Verschleissschuh
ATA46498A (de) Kunststoffgleitbahn
DE59805451D1 (de) Coilboxofen
DE59800820D1 (de) Stiellose kniegelenkendoprothese
DE59809000D1 (de) Strassenhalmkasten